CD274 and neoplasm: Assuming that OligoAR may reflect local immune resistance with otherwise sustained anti-tumor immunity, Schoenfeld et al. performed a retrospective analysis of 1536 patients treated in the Memorial Sloan Kettering Cancer Center with PD-(L)1 blockade (without chemotherapy).